{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "25",
                "@year": "2021",
                "@timestamp": "2021-07-25T10:32:55.000055-04:00",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2019",
                "@month": "10"
            }
        },
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60005558",
                            "@country": "usa",
                            "city": "Rochester",
                            "organization": [
                                {"$": "Division of Gastroenterology and Hepatology"},
                                {"$": "Mayo Clinic"}
                            ],
                            "affiliation-id": {
                                "@afid": "60005558",
                                "@dptid": "109429459"
                            },
                            "state": "MN",
                            "ce:source-text": "Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN;",
                            "@dptid": "109429459"
                        },
                        "author": [
                            {
                                "ce:given-name": "Sang Hyoung",
                                "preferred-name": {
                                    "ce:given-name": "Sang Hyoung",
                                    "ce:initials": "S.H.",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park S.H."
                                },
                                "@seq": "1",
                                "ce:initials": "S.H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Park",
                                "@auid": "34977204700",
                                "ce:indexed-name": "Park S.H."
                            },
                            {
                                "ce:given-name": "Badr",
                                "preferred-name": {
                                    "ce:given-name": "Badr",
                                    "ce:initials": "B.",
                                    "ce:surname": "Al-Bawardy",
                                    "ce:indexed-name": "Al-Bawardy B."
                                },
                                "@seq": "2",
                                "ce:initials": "B.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Al-Bawardy",
                                "@auid": "56217996100",
                                "ce:indexed-name": "Al-Bawardy B."
                            },
                            {
                                "ce:given-name": "Satimai",
                                "preferred-name": {
                                    "ce:given-name": "Satimai",
                                    "ce:initials": "S.",
                                    "ce:surname": "Aniwan",
                                    "ce:indexed-name": "Aniwan S."
                                },
                                "@seq": "3",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Aniwan",
                                "@auid": "36010544000",
                                "ce:indexed-name": "Aniwan S."
                            },
                            {
                                "ce:given-name": "Sunanda V.",
                                "preferred-name": {
                                    "ce:given-name": "Sunanda V.",
                                    "ce:initials": "S.V.",
                                    "ce:surname": "Kane",
                                    "ce:indexed-name": "Kane S.V."
                                },
                                "@seq": "4",
                                "ce:initials": "S.V.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Kane",
                                "@auid": "57203353794",
                                "ce:indexed-name": "Kane S.V."
                            },
                            {
                                "ce:given-name": "Nayantara",
                                "preferred-name": {
                                    "ce:given-name": "Nayantara",
                                    "ce:initials": "N.",
                                    "ce:surname": "Coelho-Prabhu",
                                    "ce:indexed-name": "Coelho-Prabhu N."
                                },
                                "@seq": "5",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MBBS",
                                "ce:surname": "Coelho-Prabhu",
                                "@auid": "25958006800",
                                "ce:indexed-name": "Coelho-Prabhu N."
                            },
                            {
                                "ce:given-name": "Konstantinos A.",
                                "preferred-name": {
                                    "ce:given-name": "Konstantinos A.",
                                    "ce:initials": "K.A.",
                                    "ce:surname": "Papadakis",
                                    "ce:indexed-name": "Papadakis K.A."
                                },
                                "@seq": "6",
                                "ce:initials": "K.A.",
                                "@date-locked": "2021-04-27T04:00:40.867",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Papadakis",
                                "@auid": "19335444300",
                                "ce:indexed-name": "Papadakis K.A."
                            },
                            {
                                "ce:given-name": "John B.",
                                "preferred-name": {
                                    "ce:given-name": "John B.",
                                    "ce:initials": "J.B.",
                                    "ce:surname": "Kisiel",
                                    "ce:indexed-name": "Kisiel J.B."
                                },
                                "@seq": "7",
                                "ce:initials": "J.B.",
                                "@date-locked": "2021-04-27T04:00:40.867",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Kisiel",
                                "@auid": "44361166300",
                                "ce:indexed-name": "Kisiel J.B."
                            },
                            {
                                "ce:given-name": "David H.",
                                "preferred-name": {
                                    "ce:given-name": "David H.",
                                    "ce:initials": "D.H.",
                                    "ce:surname": "Bruining",
                                    "ce:indexed-name": "Bruining D.H."
                                },
                                "@seq": "8",
                                "ce:initials": "D.H.",
                                "@date-locked": "2021-07-25T04:10:59.029",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Bruining",
                                "@auid": "16833358400",
                                "ce:indexed-name": "Bruining D.H."
                            },
                            {
                                "ce:given-name": "William A.",
                                "preferred-name": {
                                    "ce:given-name": "William A.",
                                    "ce:initials": "W.A.",
                                    "ce:surname": "Faubion",
                                    "ce:indexed-name": "Faubion W.A."
                                },
                                "@seq": "9",
                                "ce:initials": "W.A.",
                                "@date-locked": "2021-07-25T04:10:59.029",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Faubion",
                                "@auid": "6601993185",
                                "ce:indexed-name": "Faubion W.A."
                            },
                            {
                                "ce:given-name": "Laura E.",
                                "preferred-name": {
                                    "ce:given-name": "Laura E.",
                                    "ce:initials": "L.E.",
                                    "ce:surname": "Raffals",
                                    "ce:indexed-name": "Raffals L.E."
                                },
                                "@seq": "10",
                                "ce:initials": "L.E.",
                                "@date-locked": "2021-04-27T04:00:40.867",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Raffals",
                                "@auid": "54986410100",
                                "ce:indexed-name": "Raffals L.E."
                            },
                            {
                                "ce:given-name": "Darrell S.",
                                "preferred-name": {
                                    "ce:given-name": "Darrell S.",
                                    "ce:initials": "D.S.",
                                    "ce:surname": "Pardi",
                                    "ce:indexed-name": "Pardi D.S."
                                },
                                "@seq": "11",
                                "ce:initials": "D.S.",
                                "@date-locked": "2021-04-27T04:00:40.867",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Pardi",
                                "@auid": "7003722987",
                                "ce:indexed-name": "Pardi D.S."
                            },
                            {
                                "ce:given-name": "William J.",
                                "preferred-name": {
                                    "ce:given-name": "William J.",
                                    "ce:initials": "W.J.",
                                    "ce:surname": "Tremaine",
                                    "ce:indexed-name": "Tremaine W.J."
                                },
                                "@seq": "12",
                                "ce:initials": "W.J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Tremaine",
                                "@auid": "7006301261",
                                "ce:indexed-name": "Tremaine W.J."
                            },
                            {
                                "ce:given-name": "Michael C.",
                                "preferred-name": {
                                    "ce:given-name": "Michael C.",
                                    "ce:initials": "M.C.",
                                    "ce:surname": "Stephens",
                                    "ce:indexed-name": "Stephens M.C."
                                },
                                "@seq": "13",
                                "ce:initials": "M.C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Stephens",
                                "@auid": "8373869600",
                                "ce:indexed-name": "Stephens M.C."
                            },
                            {
                                "ce:given-name": "Sahil",
                                "preferred-name": {
                                    "ce:given-name": "Sahil",
                                    "ce:initials": "S.",
                                    "ce:surname": "Khanna",
                                    "ce:indexed-name": "Khanna S."
                                },
                                "@seq": "15",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MBBS",
                                "ce:surname": "Khanna",
                                "@auid": "19639178900",
                                "ce:indexed-name": "Khanna S."
                            },
                            {
                                "ce:given-name": "Edward V.",
                                "preferred-name": {
                                    "ce:given-name": "Edward V.",
                                    "ce:initials": "E.V.",
                                    "ce:surname": "Loftus",
                                    "ce:indexed-name": "Loftus E.V."
                                },
                                "@seq": "17",
                                "ce:initials": "E.V.",
                                "@date-locked": "2021-04-27T04:00:40.867",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Loftus",
                                "@auid": "7202138774",
                                "ce:suffix": "Jr.",
                                "ce:indexed-name": "Loftus E.V."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60006240",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Gastroenterology"},
                                {"$": "University of Ulsan College of Medicine"},
                                {"$": "Asan Medical Center"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60006240",
                                    "@dptid": "113669103"
                                },
                                {"@afid": "60068691"}
                            ],
                            "ce:source-text": "Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea;",
                            "@dptid": "113669103"
                        },
                        "author": [{
                            "ce:given-name": "Sang Hyoung",
                            "preferred-name": {
                                "ce:given-name": "Sang Hyoung",
                                "ce:initials": "S.H.",
                                "ce:surname": "Park",
                                "ce:indexed-name": "Park S.H."
                            },
                            "@seq": "1",
                            "ce:initials": "S.H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Park",
                            "@auid": "34977204700",
                            "ce:indexed-name": "Park S.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60017994",
                            "@country": "usa",
                            "city": "New Haven",
                            "organization": [
                                {"$": "Yale School of Medicine"},
                                {"$": "Section of Digestive Diseases"}
                            ],
                            "affiliation-id": {
                                "@afid": "60017994",
                                "@dptid": "103924191"
                            },
                            "state": "CT",
                            "ce:source-text": "Yale School of Medicine, Section of Digestive Diseases, New Haven, CT;",
                            "@dptid": "103924191"
                        },
                        "author": [{
                            "ce:given-name": "Badr",
                            "preferred-name": {
                                "ce:given-name": "Badr",
                                "ce:initials": "B.",
                                "ce:surname": "Al-Bawardy",
                                "ce:indexed-name": "Al-Bawardy B."
                            },
                            "@seq": "2",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Al-Bawardy",
                            "@auid": "56217996100",
                            "ce:indexed-name": "Al-Bawardy B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Gastroenterology"},
                                {"$": "Chulalongkorn University"},
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60028190",
                                    "@dptid": "104425746"
                                },
                                {"@afid": "60031780"},
                                {"@afid": "60022183"}
                            ],
                            "ce:source-text": "Division of Gastroenterology, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand;",
                            "@dptid": "104425746"
                        },
                        "author": [{
                            "ce:given-name": "Satimai",
                            "preferred-name": {
                                "ce:given-name": "Satimai",
                                "ce:initials": "S.",
                                "ce:surname": "Aniwan",
                                "ce:indexed-name": "Aniwan S."
                            },
                            "@seq": "3",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Aniwan",
                            "@auid": "36010544000",
                            "ce:indexed-name": "Aniwan S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60029833",
                            "@country": "usa",
                            "city": "Oklahoma City",
                            "organization": [
                                {"$": "Department of Pediatrics"},
                                {"$": "Oklahoma University Health Sciences Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60029833",
                                "@dptid": "108409804"
                            },
                            "state": "OK",
                            "ce:source-text": "Department of Pediatrics, Oklahoma University Health Sciences Center, Oklahoma City. OK; and",
                            "@dptid": "108409804"
                        },
                        "author": [{
                            "ce:given-name": "Jeanne",
                            "preferred-name": {
                                "ce:given-name": "Jeanne",
                                "ce:initials": "J.",
                                "ce:surname": "Tung",
                                "ce:indexed-name": "Tung J."
                            },
                            "@seq": "14",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Tung",
                            "@auid": "12144290900",
                            "ce:indexed-name": "Tung J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60005558",
                            "@country": "usa",
                            "city": "Rochester",
                            "organization": [
                                {"$": "Department of Laboratory Medicine and Pathology"},
                                {"$": "Mayo Clinic"}
                            ],
                            "affiliation-id": {
                                "@afid": "60005558",
                                "@dptid": "113717257"
                            },
                            "state": "MN",
                            "ce:source-text": "Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN",
                            "@dptid": "113717257"
                        },
                        "author": [{
                            "ce:given-name": "Maria Alice V.",
                            "preferred-name": {
                                "ce:given-name": "Maria Alice V.",
                                "ce:initials": "M.A.V.",
                                "ce:surname": "Willrich",
                                "ce:indexed-name": "Willrich M.A.V."
                            },
                            "@seq": "16",
                            "ce:initials": "M.A.V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "PhD",
                            "ce:surname": "Willrich",
                            "@auid": "56736400500",
                            "ce:indexed-name": "Willrich M.A.V."
                        }]
                    }
                ],
                "citation-title": "Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease",
                "abstracts": "© 2019 Crohn's & Colitis Foundation. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation.Background and Aims: We aimed to evaluate the relationship of serum adalimumab trough levels (ATL) with disease activity of inflammatory bowel disease (IBD) patients in a large, well-characterized referral center-based cohort. Methods: We compared serum ATL between those with clinical, biochemical, or endoscopic/radiologic disease activity and those without. Results: A total of 236 patients with IBD were included. Higher cutoff levels were associated with endoscopic and/or radiologic responses (cutoff value: 5.3 mcg/mL, P = 0.003) compared with improvement in C-reactive protein (cutoff value: 4.3 mcg/mL, P = 0.031). Conclusions: Higher cutoff ATL was associated with endoscopic and/or radiologic response.",
                "correspondence": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "address-part": "200 First St. SW",
                            "postal-code": "55905",
                            "@country": "usa",
                            "city": "Rochester",
                            "organization": [
                                {"$": "Division of Gastroenterology and Hepatology"},
                                {"$": "Mayo Clinic College of Medicine"}
                            ],
                            "state": "MN",
                            "ce:source-text": "Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55905"
                        },
                        "person": {
                            "ce:given-name": "Edward V.",
                            "ce:initials": "E.V.",
                            "ce:degrees": "MD",
                            "ce:surname": "Loftus",
                            "ce:suffix": "Jr.",
                            "ce:indexed-name": "Loftus E.V."
                        }
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "address-part": "88, Olympic-ro 43-gil, Songpa-gu",
                            "postal-code": "05505",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Gastroenterology"},
                                {"$": "Asan Medical Center"},
                                {"$": "University of Ulsan College of Medicine"}
                            ],
                            "ce:source-text": "Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea"
                        },
                        "person": {
                            "ce:given-name": "Sang Hyoung",
                            "ce:initials": "S.H.",
                            "ce:degrees": "MD",
                            "ce:surname": "Park",
                            "ce:indexed-name": "Park S.H."
                        }
                    }
                ],
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Adalimumab",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Inflammatory bowel disease",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Therapeutic drug monitoring",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Crohn's Colitis 360",
                    "website": {"ce:e-address": {
                        "$": "https://academic.oup.com/crohnscolitis360",
                        "@type": "email"
                    }},
                    "@country": "gbr",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": {
                        "$": "2631827X",
                        "@type": "electronic"
                    },
                    "volisspag": {"voliss": {
                        "@volume": "1",
                        "@issue": "3"
                    }},
                    "@type": "j",
                    "publicationyear": {"@first": "2019"},
                    "publisher": {"publishername": "Oxford University Press"},
                    "sourcetitle": "Crohn's and Colitis 360",
                    "@srcid": "21101041955",
                    "publicationdate": {
                        "month": "10",
                        "year": "2019",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 October 2019"
                        },
                        "day": "01"
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "ASJC",
                            "classification": "2715"
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "17",
                                    "classification-description": "Public Health, Social Medicine and Epidemiology"
                                },
                                {
                                    "classification-code": "26",
                                    "classification-description": "Immunology, Serology and Transplantation"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                },
                                {
                                    "classification-code": "9",
                                    "classification-description": "Surgery"
                                }
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": [
                            {
                                "cas-registry-number": [
                                    {"$": "331731-18-1"},
                                    {"$": "1446410-95-2"}
                                ],
                                "chemical-name": "adalimumab"
                            },
                            {
                                "cas-registry-number": "446-86-6",
                                "chemical-name": "azathioprine"
                            },
                            {
                                "cas-registry-number": "9007-41-4",
                                "chemical-name": "C reactive protein"
                            },
                            {
                                "cas-registry-number": "428863-50-7",
                                "chemical-name": "certolizumab pegol"
                            },
                            {
                                "cas-registry-number": "476181-74-5",
                                "chemical-name": "golimumab"
                            },
                            {
                                "cas-registry-number": "170277-31-3",
                                "chemical-name": "infliximab"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "31441-78-8"},
                                    {"$": "50-44-2"},
                                    {"$": "6112-76-1"}
                                ],
                                "chemical-name": "mercaptopurine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "15475-56-6"},
                                    {"$": "59-05-2"},
                                    {"$": "7413-34-5"},
                                    {"$": "7532-09-4"},
                                    {"$": "6745-93-3"}
                                ],
                                "chemical-name": "methotrexate"
                            },
                            {
                                "cas-registry-number": "189261-10-7",
                                "chemical-name": "natalizumab"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "815610-63-0"},
                                    {"$": "949907-93-1"}
                                ],
                                "chemical-name": "ustekinumab"
                            },
                            {
                                "cas-registry-number": "943609-66-3",
                                "chemical-name": "vedolizumab"
                            }
                        ]
                    }}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "12",
                    "@year": "2021",
                    "@timestamp": "BST 18:36:19",
                    "@month": "04"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "632463877",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "927287096",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20200629866",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "20201622733",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20211170691",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85086025052",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85086025052",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.1093/crocol/otz047"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "27",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Danese S. New therapies for inflammatory bowel disease: from the bench to the bedside. Gut. 2012;61:918-932.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "New therapies for inflammatory bowel disease: from the bench to the bedside"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84860557456",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "61"},
                                "pagerange": {
                                    "@first": "918",
                                    "@last": "932"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "ce:surname": "Danese",
                                "ce:indexed-name": "Danese S."
                            }]},
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "Danese S. New therapies for inflammatory bowel disease: from the bench to the bedside. Gut. 2012;61:918-932."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Hanauer SB, Feagan BG, Lichtenstein GR, et al.; ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359:1541-1549.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037018761",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "359"},
                                "pagerange": {
                                    "@first": "1541",
                                    "@last": "1549"
                                }
                            },
                            "ref-text": "ACCENT I Study Group",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SB",
                                        "@_fa": "true",
                                        "ce:surname": "Hanauer",
                                        "ce:indexed-name": "Hanauer SB"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GR",
                                        "@_fa": "true",
                                        "ce:surname": "Lichtenstein",
                                        "ce:indexed-name": "Lichtenstein GR"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Hanauer SB, Feagan BG, Lichtenstein GR, et al.; ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359:1541-1549."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology. 2007;132:52-65.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33846242958",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "132"},
                                "pagerange": {
                                    "@first": "52",
                                    "@last": "65"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology. 2007;132:52-65."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Schreiber S, Khaliq-Kareemi M, Lawrance IC, et al.; PRECISE 2 Study Investigators. Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med. 2007;357:239-250.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Maintenance therapy with certolizumab pegol for Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34447515607",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "357"},
                                "pagerange": {
                                    "@first": "239",
                                    "@last": "250"
                                }
                            },
                            "ref-text": "PRECISE 2 Study Investigators",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Schreiber",
                                        "ce:indexed-name": "Schreiber S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Khaliq-Kareemi",
                                        "ce:indexed-name": "Khaliq-Kareemi M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "IC",
                                        "@_fa": "true",
                                        "ce:surname": "Lawrance",
                                        "ce:indexed-name": "Lawrance IC"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Schreiber S, Khaliq-Kareemi M, Lawrance IC, et al.; PRECISE 2 Study Investigators. Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med. 2007;357:239-250."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Singh S, Pardi DS. Update on anti-tumor necrosis factor agents in Crohn disease. Gastroenterol Clin North Am. 2014;43:457-478.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Update on anti-tumor necrosis factor agents in Crohn disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84905723625",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "43"},
                                "pagerange": {
                                    "@first": "457",
                                    "@last": "478"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Singh",
                                    "ce:indexed-name": "Singh S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "DS.",
                                    "@_fa": "true",
                                    "ce:surname": "Pardi",
                                    "ce:indexed-name": "Pardi DS."
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterol Clin North Am"
                        },
                        "ce:source-text": "Singh S, Pardi DS. Update on anti-tumor necrosis factor agents in Crohn disease. Gastroenterol Clin North Am. 2014;43:457-478."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Vande Casteele N, Feagan BG, Gils A, et al. Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives. Curr Gastroenterol Rep. 2014;16:378.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84894640694",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {"@first": "378"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Vande Casteele",
                                        "ce:indexed-name": "Vande Casteele N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Gils",
                                        "ce:indexed-name": "Gils A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Curr Gastroenterol Rep"
                        },
                        "ce:source-text": "Vande Casteele N, Feagan BG, Gils A, et al. Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives. Curr Gastroenterol Rep. 2014;16:378."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Vande Casteele N, Herfarth H, Katz J, et al. American gastroenterological association institute technical review on the role of therapeutic drug monitoring in the management of inflammatory bowel diseases. Gastroenterology. 2017;153:835-857.e6.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "American gastroenterological association institute technical review on the role of therapeutic drug monitoring in the management of inflammatory bowel diseases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85028868958",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "153"},
                                "pagerange": {
                                    "@first": "835",
                                    "@last": "857"
                                }
                            },
                            "ref-text": "e6",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Vande Casteele",
                                        "ce:indexed-name": "Vande Casteele N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Herfarth",
                                        "ce:indexed-name": "Herfarth H"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Katz",
                                        "ce:indexed-name": "Katz J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Vande Casteele N, Herfarth H, Katz J, et al. American gastroenterological association institute technical review on the role of therapeutic drug monitoring in the management of inflammatory bowel diseases. Gastroenterology. 2017;153:835-857.e6."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Maser EA, Villela R, Silverberg MS, Greenberg GR. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. Clin Gastroenterol Hepatol. 2006;4:1248-1254.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33749432435",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "1248",
                                    "@last": "1254"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "EA",
                                    "@_fa": "true",
                                    "ce:surname": "Maser",
                                    "ce:indexed-name": "Maser EA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Villela",
                                    "ce:indexed-name": "Villela R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "MS",
                                    "@_fa": "true",
                                    "ce:surname": "Silverberg",
                                    "ce:indexed-name": "Silverberg MS"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "GR.",
                                    "@_fa": "true",
                                    "ce:surname": "Greenberg",
                                    "ce:indexed-name": "Greenberg GR."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Maser EA, Villela R, Silverberg MS, Greenberg GR. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. Clin Gastroenterol Hepatol. 2006;4:1248-1254."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Oh EH, Ko DH, Seo H, et al. Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn's disease. World J Gastroenterol. 2017;23:1489-1496.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85015061985",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "1489",
                                    "@last": "1496"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "EH",
                                        "@_fa": "true",
                                        "ce:surname": "Oh",
                                        "ce:indexed-name": "Oh EH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DH",
                                        "@_fa": "true",
                                        "ce:surname": "Ko",
                                        "ce:indexed-name": "Ko DH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Seo",
                                        "ce:indexed-name": "Seo H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "World J Gastroenterol"
                        },
                        "ce:source-text": "Oh EH, Ko DH, Seo H, et al. Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn's disease. World J Gastroenterol. 2017;23:1489-1496."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Seow CH, Newman A, Irwin SP, et al. Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut. 2010;59:49-54.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "73449088039",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "59"},
                                "pagerange": {
                                    "@first": "49",
                                    "@last": "54"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CH",
                                        "@_fa": "true",
                                        "ce:surname": "Seow",
                                        "ce:indexed-name": "Seow CH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Newman",
                                        "ce:indexed-name": "Newman A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SP",
                                        "@_fa": "true",
                                        "ce:surname": "Irwin",
                                        "ce:indexed-name": "Irwin SP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "Seow CH, Newman A, Irwin SP, et al. Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut. 2010;59:49-54."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Yarur AJ, Kanagala V, Stein DJ, et al. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Aliment Pharmacol Ther. 2017;45:933-940.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85013449857",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "933",
                                    "@last": "940"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AJ",
                                        "@_fa": "true",
                                        "ce:surname": "Yarur",
                                        "ce:indexed-name": "Yarur AJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Kanagala",
                                        "ce:indexed-name": "Kanagala V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "DJ",
                                        "@_fa": "true",
                                        "ce:surname": "Stein",
                                        "ce:indexed-name": "Stein DJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "Yarur AJ, Kanagala V, Stein DJ, et al. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease. Aliment Pharmacol Ther. 2017;45:933-940."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Ward MG, Warner B, Unsworth N, et al. Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors. Aliment Pharmacol Ther. 2017;46:150-161.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85019033667",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "46"},
                                "pagerange": {
                                    "@first": "150",
                                    "@last": "161"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MG",
                                        "@_fa": "true",
                                        "ce:surname": "Ward",
                                        "ce:indexed-name": "Ward MG"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Warner",
                                        "ce:indexed-name": "Warner B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Unsworth",
                                        "ce:indexed-name": "Unsworth N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "Ward MG, Warner B, Unsworth N, et al. Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors. Aliment Pharmacol Ther. 2017;46:150-161."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Ward MG, Thwaites PA, Beswick L, et al. Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease. Aliment Pharmacol Ther. 2017;45:1135-1145.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85013787029",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "1135",
                                    "@last": "1145"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MG",
                                        "@_fa": "true",
                                        "ce:surname": "Ward",
                                        "ce:indexed-name": "Ward MG"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "PA",
                                        "@_fa": "true",
                                        "ce:surname": "Thwaites",
                                        "ce:indexed-name": "Thwaites PA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Beswick",
                                        "ce:indexed-name": "Beswick L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "Ward MG, Thwaites PA, Beswick L, et al. Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease. Aliment Pharmacol Ther. 2017;45:1135-1145."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Al-Bawardy B, Ramos GP, Willrich MAV, et al. Vedolizumab drug level correlation with clinical remission, biomarker normalization, and mucosal healing in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:580-586.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Vedolizumab drug level correlation with clinical remission, biomarker normalization, and mucosal healing in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85061989001",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "580",
                                    "@last": "586"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Al-Bawardy",
                                        "ce:indexed-name": "Al-Bawardy B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "GP",
                                        "@_fa": "true",
                                        "ce:surname": "Ramos",
                                        "ce:indexed-name": "Ramos GP"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MAV",
                                        "@_fa": "true",
                                        "ce:surname": "Willrich",
                                        "ce:indexed-name": "Willrich MAV"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "Al-Bawardy B, Ramos GP, Willrich MAV, et al. Vedolizumab drug level correlation with clinical remission, biomarker normalization, and mucosal healing in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:580-586."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Juncadella A, Papamichael K, Vaughn BP, Cheifetz AS. Maintenance adalimumab concentrations are associated with biochemical, endoscopic, and histologic remission in inflammatory bowel disease. Dig Dis Sci. 2018;63:3067-3073.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Maintenance adalimumab concentrations are associated with biochemical, endoscopic, and histologic remission in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85049845073",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "3067",
                                    "@last": "3073"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Juncadella",
                                    "ce:indexed-name": "Juncadella A"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Papamichael",
                                    "ce:indexed-name": "Papamichael K"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "BP",
                                    "@_fa": "true",
                                    "ce:surname": "Vaughn",
                                    "ce:indexed-name": "Vaughn BP"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "AS.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheifetz",
                                    "ce:indexed-name": "Cheifetz AS."
                                }
                            ]},
                            "ref-sourcetitle": "Dig Dis Sci"
                        },
                        "ce:source-text": "Juncadella A, Papamichael K, Vaughn BP, Cheifetz AS. Maintenance adalimumab concentrations are associated with biochemical, endoscopic, and histologic remission in inflammatory bowel disease. Dig Dis Sci. 2018;63:3067-3073."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Plevris N, Lyons M, Jenkinson PW, et al. Higher adalimumab drug levels during maintenance therapy for Crohn's disease are associated with biologic remission. Inflamm Bowel Dis. 2019;25:1036-1043.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Higher adalimumab drug levels during maintenance therapy for Crohn's disease are associated with biologic remission"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85065674569",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "1036",
                                    "@last": "1043"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Plevris",
                                        "ce:indexed-name": "Plevris N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lyons",
                                        "ce:indexed-name": "Lyons M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "PW",
                                        "@_fa": "true",
                                        "ce:surname": "Jenkinson",
                                        "ce:indexed-name": "Jenkinson PW"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "Plevris N, Lyons M, Jenkinson PW, et al. Higher adalimumab drug levels during maintenance therapy for Crohn's disease are associated with biologic remission. Inflamm Bowel Dis. 2019;25:1036-1043."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Watanabe K, Matsumoto T, Hisamatsu T, et al.; DIAMOND Study Group. Clinical and pharmacokinetic factors associated with adalimumab-induced mucosal healing in patients with Crohn's disease. Clin Gastroenterol Hepatol. 2018;16:542-549.e1.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Clinical and pharmacokinetic factors associated with adalimumab-induced mucosal healing in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85043997414",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "542",
                                    "@last": "549"
                                }
                            },
                            "ref-text": "DIAMOND Study Group. ;: e1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Watanabe",
                                        "ce:indexed-name": "Watanabe K"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Matsumoto",
                                        "ce:indexed-name": "Matsumoto T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Hisamatsu",
                                        "ce:indexed-name": "Hisamatsu T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Watanabe K, Matsumoto T, Hisamatsu T, et al.; DIAMOND Study Group. Clinical and pharmacokinetic factors associated with adalimumab-induced mucosal healing in patients with Crohn's disease. Clin Gastroenterol Hepatol. 2018;16:542-549.e1."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Peyrin-Biroulet L, Reinisch W, Colombel JF, et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut. 2014;63:88-95.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84888400869",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "88",
                                    "@last": "95"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Peyrin-Biroulet",
                                        "ce:indexed-name": "Peyrin-Biroulet L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Reinisch",
                                        "ce:indexed-name": "Reinisch W"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "Peyrin-Biroulet L, Reinisch W, Colombel JF, et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut. 2014;63:88-95."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:1246-56.e6.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84904393612",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "1246",
                                    "@last": "1256"
                                }
                            },
                            "ref-text": "e6",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Williet",
                                    "ce:indexed-name": "Williet N"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "WJ",
                                    "@_fa": "true",
                                    "ce:surname": "Sandborn",
                                    "ce:indexed-name": "Sandborn WJ"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Peyrin-Biroulet",
                                    "ce:indexed-name": "Peyrin-Biroulet L."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:1246-56.e6."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Bruining DH, Zimmermann EM, Loftus EV Jr, et al.; Society of Abdominal Radiology Crohn's Disease-Focused Panel. Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn's disease. Gastroenterology. 2018;154:1172-1194.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85040377567",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "154"},
                                "pagerange": {
                                    "@first": "1172",
                                    "@last": "1194"
                                }
                            },
                            "ref-text": "Society of Abdominal Radiology Crohn's Disease-Focused Panel",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DH",
                                        "@_fa": "true",
                                        "ce:surname": "Bruining",
                                        "ce:indexed-name": "Bruining DH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "EM",
                                        "@_fa": "true",
                                        "ce:surname": "Zimmermann",
                                        "ce:indexed-name": "Zimmermann EM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "EV",
                                        "@_fa": "true",
                                        "ce:surname": "Loftus",
                                        "ce:indexed-name": "Loftus EV"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Bruining DH, Zimmermann EM, Loftus EV Jr, et al.; Society of Abdominal Radiology Crohn's Disease-Focused Panel. Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn's disease. Gastroenterology. 2018;154:1172-1194."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Park SH, Aniwan S, Loftus EV Jr. Advances in the use of biologics and other novel drugs for managing inflammatory bowel disease. Curr Opin Pharmacol. 2017;37:65-71.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Advances in the use of biologics and other novel drugs for managing inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85030719959",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "65",
                                    "@last": "71"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "SH",
                                    "@_fa": "true",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park SH"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Aniwan",
                                    "ce:indexed-name": "Aniwan S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "EV",
                                    "@_fa": "true",
                                    "ce:surname": "Loftus",
                                    "ce:indexed-name": "Loftus EV"
                                }
                            ]},
                            "ref-sourcetitle": "Curr Opin Pharmacol"
                        },
                        "ce:source-text": "Park SH, Aniwan S, Loftus EV Jr. Advances in the use of biologics and other novel drugs for managing inflammatory bowel disease. Curr Opin Pharmacol. 2017;37:65-71."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Silva-Ferreira F, Afonso J, Pinto-Lopes P, Magro F. A systematic review on infliximab and adalimumab drug monitoring: levels, clinical outcomes and assays. Inflamm Bowel Dis. 2016;22:2289-2301.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "A systematic review on infliximab and adalimumab drug monitoring: levels, clinical outcomes and assays"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84983672130",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "2289",
                                    "@last": "2301"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Silva-Ferreira",
                                    "ce:indexed-name": "Silva-Ferreira F"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Afonso",
                                    "ce:indexed-name": "Afonso J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Pinto-Lopes",
                                    "ce:indexed-name": "Pinto-Lopes P"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Magro",
                                    "ce:indexed-name": "Magro F."
                                }
                            ]},
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "Silva-Ferreira F, Afonso J, Pinto-Lopes P, Magro F. A systematic review on infliximab and adalimumab drug monitoring: levels, clinical outcomes and assays. Inflamm Bowel Dis. 2016;22:2289-2301."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Vande Casteele N, Ferrante M, Van Assche G, et al. Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease. Gastroenterology. 2015;148:1320-1329.e3.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84930015437",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "148"},
                                "pagerange": {
                                    "@first": "1320",
                                    "@last": "1329"
                                }
                            },
                            "ref-text": "e3",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Vande Casteele",
                                        "ce:indexed-name": "Vande Casteele N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Ferrante",
                                        "ce:indexed-name": "Ferrante M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Van Assche",
                                        "ce:indexed-name": "Van Assche G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Vande Casteele N, Ferrante M, Van Assche G, et al. Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease. Gastroenterology. 2015;148:1320-1329.e3."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Zittan E, Kabakchiev B, Milgrom R, et al. Higher adalimumab drug levels are associated with mucosal healing in patients with Crohn's disease. J Crohns Colitis. 2016;10:510-515.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Higher adalimumab drug levels are associated with mucosal healing in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84982199930",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "510",
                                    "@last": "515"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Zittan",
                                        "ce:indexed-name": "Zittan E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Kabakchiev",
                                        "ce:indexed-name": "Kabakchiev B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Milgrom",
                                        "ce:indexed-name": "Milgrom R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "Zittan E, Kabakchiev B, Milgrom R, et al. Higher adalimumab drug levels are associated with mucosal healing in patients with Crohn's disease. J Crohns Colitis. 2016;10:510-515."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Yarur AJ, Jain A, Hauenstein SI, et al. Higher adalimumab levels are associated with histologic and endoscopic remission in patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2016;22:409-415.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Higher adalimumab levels are associated with histologic and endoscopic remission in patients with Crohn's disease and ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84955604767",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "409",
                                    "@last": "415"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AJ",
                                        "@_fa": "true",
                                        "ce:surname": "Yarur",
                                        "ce:indexed-name": "Yarur AJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Jain",
                                        "ce:indexed-name": "Jain A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SI",
                                        "@_fa": "true",
                                        "ce:surname": "Hauenstein",
                                        "ce:indexed-name": "Hauenstein SI"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "Yarur AJ, Jain A, Hauenstein SI, et al. Higher adalimumab levels are associated with histologic and endoscopic remission in patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2016;22:409-415."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "Steenholdt C, Brynskov J, Thomsen OØ, et al. Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial. Gut. 2014;63:919-927.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84899915498",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "919",
                                    "@last": "927"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Steenholdt",
                                        "ce:indexed-name": "Steenholdt C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Brynskov",
                                        "ce:indexed-name": "Brynskov J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "OØ",
                                        "@_fa": "true",
                                        "ce:surname": "Thomsen",
                                        "ce:indexed-name": "Thomsen OO"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "Steenholdt C, Brynskov J, Thomsen OØ, et al. Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial. Gut. 2014;63:919-927."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.88",
                        "ref-fulltext": "D'Haens G, Vermeire S, Lambrecht G, et al.; GETAID. Increasing infliximab dose based on symptoms, biomarkers, and serum drug concentrations does not increase clinical, endoscopic, and corticosteroid-free remission in patients with active luminal Crohn's disease. Gastroenterology. 2018;154:1343-1351.e1.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Increasing infliximab dose based on symptoms, biomarkers, and serum drug concentrations does not increase clinical, endoscopic, and corticosteroid-free remission in patients with active luminal Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85044617922",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "154"},
                                "pagerange": {
                                    "@first": "1343",
                                    "@last": "1351"
                                }
                            },
                            "ref-text": "GETAID. ;: e1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "D'Haens",
                                        "ce:indexed-name": "D'Haens G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Vermeire",
                                        "ce:indexed-name": "Vermeire S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Lambrecht",
                                        "ce:indexed-name": "Lambrecht G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "D'Haens G, Vermeire S, Lambrecht G, et al.; GETAID. Increasing infliximab dose based on symptoms, biomarkers, and serum drug concentrations does not increase clinical, endoscopic, and corticosteroid-free remission in patients with active luminal Crohn's disease. Gastroenterology. 2018;154:1343-1351.e1."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Rochester",
            "@id": "60005558",
            "affilname": "Mayo Clinic",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Oklahoma City",
            "@id": "60029833",
            "affilname": "University of Oklahoma Health Sciences Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029833",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New Haven",
            "@id": "60017994",
            "affilname": "Yale School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017994",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60006240",
            "affilname": "University of Ulsan College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240",
            "affiliation-country": "South Korea"
        }
    ],
    "coredata": {
        "srctype": "j",
        "prism:issueIdentifier": "3",
        "eid": "2-s2.0-85086025052",
        "dc:description": "Background and Aims: We aimed to evaluate the relationship of serum adalimumab trough levels (ATL) with disease activity of inflammatory bowel disease (IBD) patients in a large, well-characterized referral center-based cohort. Methods: We compared serum ATL between those with clinical, biochemical, or endoscopic/radiologic disease activity and those without. Results: A total of 236 patients with IBD were included. Higher cutoff levels were associated with endoscopic and/or radiologic responses (cutoff value: 5.3 mcg/mL, P = 0.003) compared with improvement in C-reactive protein (cutoff value: 4.3 mcg/mL, P = 0.031). Conclusions: Higher cutoff ATL was associated with endoscopic and/or radiologic response.",
        "prism:coverDate": "2019-10-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85086025052",
        "subtypeDescription": "Article",
        "dc:creator": {"author": [{
            "ce:given-name": "Sang Hyoung",
            "preferred-name": {
                "ce:given-name": "Sang Hyoung",
                "ce:initials": "S.H.",
                "ce:surname": "Park",
                "ce:indexed-name": "Park S.H."
            },
            "@seq": "1",
            "ce:initials": "S.H.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60005558",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
                },
                {
                    "@id": "60006240",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Park",
            "@auid": "34977204700",
            "author-url": "https://api.elsevier.com/content/author/author_id/34977204700",
            "ce:indexed-name": "Park S.H."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85086025052"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086025052&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85086025052&origin=inward"
            }
        ],
        "prism:publicationName": "Crohn's and Colitis 360",
        "source-id": "21101041955",
        "citedby-count": "3",
        "prism:volume": "1",
        "subtype": "ar",
        "dc:title": "Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease",
        "openaccess": "1",
        "openaccessFlag": "true",
        "prism:doi": "10.1093/crocol/otz047",
        "prism:issn": "2631827X",
        "publishercopyright": "© 2019 Crohn's & Colitis Foundation. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation.",
        "dc:identifier": "SCOPUS_ID:85086025052",
        "dc:publisher": "Oxford University Press"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Adalimumab"
        },
        {
            "@_fa": "true",
            "$": "Inflammatory bowel disease"
        },
        {
            "@_fa": "true",
            "$": "Therapeutic drug monitoring"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Gastroenterology",
        "@code": "2715",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Sang Hyoung",
            "preferred-name": {
                "ce:given-name": "Sang Hyoung",
                "ce:initials": "S.H.",
                "ce:surname": "Park",
                "ce:indexed-name": "Park S.H."
            },
            "@seq": "1",
            "ce:initials": "S.H.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60005558",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
                },
                {
                    "@id": "60006240",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Park",
            "@auid": "34977204700",
            "author-url": "https://api.elsevier.com/content/author/author_id/34977204700",
            "ce:indexed-name": "Park S.H."
        },
        {
            "ce:given-name": "Badr",
            "preferred-name": {
                "ce:given-name": "Badr",
                "ce:initials": "B.",
                "ce:surname": "Al-Bawardy",
                "ce:indexed-name": "Al-Bawardy B."
            },
            "@seq": "2",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60005558",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
                },
                {
                    "@id": "60017994",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017994"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Al-Bawardy",
            "@auid": "56217996100",
            "author-url": "https://api.elsevier.com/content/author/author_id/56217996100",
            "ce:indexed-name": "Al-Bawardy B."
        },
        {
            "ce:given-name": "Satimai",
            "preferred-name": {
                "ce:given-name": "Satimai",
                "ce:initials": "S.",
                "ce:surname": "Aniwan",
                "ce:indexed-name": "Aniwan S."
            },
            "@seq": "3",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60005558",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
                },
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                }
            ],
            "ce:degrees": "MD",
            "ce:surname": "Aniwan",
            "@auid": "36010544000",
            "author-url": "https://api.elsevier.com/content/author/author_id/36010544000",
            "ce:indexed-name": "Aniwan S."
        },
        {
            "ce:given-name": "Sunanda V.",
            "preferred-name": {
                "ce:given-name": "Sunanda V.",
                "ce:initials": "S.V.",
                "ce:surname": "Kane",
                "ce:indexed-name": "Kane S.V."
            },
            "@seq": "4",
            "ce:initials": "S.V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Kane",
            "@auid": "57203353794",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203353794",
            "ce:indexed-name": "Kane S.V."
        },
        {
            "ce:given-name": "Nayantara",
            "preferred-name": {
                "ce:given-name": "Nayantara",
                "ce:initials": "N.",
                "ce:surname": "Coelho-Prabhu",
                "ce:indexed-name": "Coelho-Prabhu N."
            },
            "@seq": "5",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MBBS",
            "ce:surname": "Coelho-Prabhu",
            "@auid": "25958006800",
            "author-url": "https://api.elsevier.com/content/author/author_id/25958006800",
            "ce:indexed-name": "Coelho-Prabhu N."
        },
        {
            "ce:given-name": "Konstantinos A.",
            "preferred-name": {
                "ce:given-name": "Konstantinos A.",
                "ce:initials": "K.A.",
                "ce:surname": "Papadakis",
                "ce:indexed-name": "Papadakis K.A."
            },
            "@seq": "6",
            "ce:initials": "K.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Papadakis",
            "@auid": "19335444300",
            "author-url": "https://api.elsevier.com/content/author/author_id/19335444300",
            "ce:indexed-name": "Papadakis K.A."
        },
        {
            "ce:given-name": "John B.",
            "preferred-name": {
                "ce:given-name": "John B.",
                "ce:initials": "J.B.",
                "ce:surname": "Kisiel",
                "ce:indexed-name": "Kisiel J.B."
            },
            "@seq": "7",
            "ce:initials": "J.B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Kisiel",
            "@auid": "44361166300",
            "author-url": "https://api.elsevier.com/content/author/author_id/44361166300",
            "ce:indexed-name": "Kisiel J.B."
        },
        {
            "ce:given-name": "David H.",
            "preferred-name": {
                "ce:given-name": "David H.",
                "ce:initials": "D.H.",
                "ce:surname": "Bruining",
                "ce:indexed-name": "Bruining D.H."
            },
            "@seq": "8",
            "ce:initials": "D.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Bruining",
            "@auid": "16833358400",
            "author-url": "https://api.elsevier.com/content/author/author_id/16833358400",
            "ce:indexed-name": "Bruining D.H."
        },
        {
            "ce:given-name": "William A.",
            "preferred-name": {
                "ce:given-name": "William A.",
                "ce:initials": "W.A.",
                "ce:surname": "Faubion",
                "ce:indexed-name": "Faubion W.A."
            },
            "@seq": "9",
            "ce:initials": "W.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Faubion",
            "@auid": "6601993185",
            "author-url": "https://api.elsevier.com/content/author/author_id/6601993185",
            "ce:indexed-name": "Faubion W.A."
        },
        {
            "ce:given-name": "Laura E.",
            "preferred-name": {
                "ce:given-name": "Laura E.",
                "ce:initials": "L.E.",
                "ce:surname": "Raffals",
                "ce:indexed-name": "Raffals L.E."
            },
            "@seq": "10",
            "ce:initials": "L.E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Raffals",
            "@auid": "54986410100",
            "author-url": "https://api.elsevier.com/content/author/author_id/54986410100",
            "ce:indexed-name": "Raffals L.E."
        },
        {
            "ce:given-name": "Darrell S.",
            "preferred-name": {
                "ce:given-name": "Darrell S.",
                "ce:initials": "D.S.",
                "ce:surname": "Pardi",
                "ce:indexed-name": "Pardi D.S."
            },
            "@seq": "11",
            "ce:initials": "D.S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Pardi",
            "@auid": "7003722987",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003722987",
            "ce:indexed-name": "Pardi D.S."
        },
        {
            "ce:given-name": "William J.",
            "preferred-name": {
                "ce:given-name": "William J.",
                "ce:initials": "W.J.",
                "ce:surname": "Tremaine",
                "ce:indexed-name": "Tremaine W.J."
            },
            "@seq": "12",
            "ce:initials": "W.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Tremaine",
            "@auid": "7006301261",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006301261",
            "ce:indexed-name": "Tremaine W.J."
        },
        {
            "ce:given-name": "Michael C.",
            "preferred-name": {
                "ce:given-name": "Michael C.",
                "ce:initials": "M.C.",
                "ce:surname": "Stephens",
                "ce:indexed-name": "Stephens M.C."
            },
            "@seq": "13",
            "ce:initials": "M.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Stephens",
            "@auid": "8373869600",
            "author-url": "https://api.elsevier.com/content/author/author_id/8373869600",
            "ce:indexed-name": "Stephens M.C."
        },
        {
            "ce:given-name": "Jeanne",
            "preferred-name": {
                "ce:given-name": "Jeanne",
                "ce:initials": "J.",
                "ce:surname": "Tung",
                "ce:indexed-name": "Tung J."
            },
            "@seq": "14",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60029833",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029833"
            },
            "ce:degrees": "MD",
            "ce:surname": "Tung",
            "@auid": "12144290900",
            "author-url": "https://api.elsevier.com/content/author/author_id/12144290900",
            "ce:indexed-name": "Tung J."
        },
        {
            "ce:given-name": "Sahil",
            "preferred-name": {
                "ce:given-name": "Sahil",
                "ce:initials": "S.",
                "ce:surname": "Khanna",
                "ce:indexed-name": "Khanna S."
            },
            "@seq": "15",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MBBS",
            "ce:surname": "Khanna",
            "@auid": "19639178900",
            "author-url": "https://api.elsevier.com/content/author/author_id/19639178900",
            "ce:indexed-name": "Khanna S."
        },
        {
            "ce:given-name": "Maria Alice V.",
            "preferred-name": {
                "ce:given-name": "Maria Alice V.",
                "ce:initials": "M.A.V.",
                "ce:surname": "Willrich",
                "ce:indexed-name": "Willrich M.A.V."
            },
            "@seq": "16",
            "ce:initials": "M.A.V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Willrich",
            "@auid": "56736400500",
            "author-url": "https://api.elsevier.com/content/author/author_id/56736400500",
            "ce:indexed-name": "Willrich M.A.V."
        },
        {
            "ce:given-name": "Edward V.",
            "preferred-name": {
                "ce:given-name": "Edward V.",
                "ce:initials": "E.V.",
                "ce:surname": "Loftus",
                "ce:indexed-name": "Loftus E.V."
            },
            "@seq": "17",
            "ce:initials": "E.V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005558",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558"
            },
            "ce:degrees": "MD",
            "ce:surname": "Loftus",
            "@auid": "7202138774",
            "ce:suffix": "Jr.",
            "author-url": "https://api.elsevier.com/content/author/author_id/7202138774",
            "ce:indexed-name": "Loftus E.V."
        }
    ]}
}}